The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     Alton Sartor Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Abdera Thereapeutics; Actithera; Advancell; Advancell; ARTbio; Asta; Azurna; BioNTech SE; Cardinal Health; Clarity Pharmaceuticals; Convergent Therapeutics; Curadh; Curadh; Lilly; NVision; Ratiopharm; Telix Pharmaceuticals; United Health Group Honoraria - Actinium Pharmaceuticals; Advancell; AstraZeneca; Clarity Pharmaceuticals; Convergent Therapeutics; Intellisphere; Lantheus Medical Imaging; Pfizer; Point Therapeutics; Ratiopharm; Sanofi; Telix Pharmaceuticals Consulting or Advisory Role - Abdera Thereapeutics; Actinium Pharmaceuticals; Actithera; Advancell; Alpha9; Amgen; ARTbio; Astellas Pharma; AstraZeneca; Bayer; Clarity Pharmaceuticals; Convergent Therapeutics; Curdah; Curium Pharma; Full Life; Fusion Pharmaceuticals; Isotopen Technologien; Janssen; Johnson & Johnson/Janssen; Lantheus Medical Imaging; Merck; Modex; Norroy; NorthStar; Novartis; Nucleus Radiopharma; NVision; Pfizer; Point Biopharma; Precede Bio; Progenics; Ratiopharm; Sanofi; Swiss Rockets; Syneos Health; Telix Pharmaceuticals; Telix Pharmaceuticals; Wren Laboratories; X-Cancer Software Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Janssen; Lantheus Medical Imaging (Inst); Novartis (Inst) Expert Testimony - Sanofi Travel, Accommodations, Expenses - Bayer; Lantheus Medical Imaging; Sanofi   Elisabeth Heath Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen; Johnson & Johnson/Janssen; Sanofi; Seagen Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Gilead Sciences; Novartis; Novartis; Sanofi Speakers' Bureau - Sanofi Research Funding - Arvinas (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); BioXCel therapeutics (Inst); Bristol-Myers Squibb (Inst); Calibr (Inst); Calithera Biosciences (Inst); Caris Life Sciences (Inst); Corcept Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo Inc. (Inst); Eisai (Inst); Exelixis (Inst); Five Prime Therapeutics (Inst); Fortis (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Infinity Pharmaceuticals (Inst); ITeos Therapeutics (Inst); Janssen Research & Development (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Modra Pharmaceuticals (Inst); Novartis (Inst); Oncolys BioPharma (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); POINT Biopharma (Inst); Roche (Inst); Seagen (Inst) Travel, Accommodations, Expenses - Sanofi Other Relationship - Caris Centers of Excellence   Neal Shore Stock and Other Ownership Interests - Photocure Consulting or Advisory Role - Accord Research; Alessa Therapeutics; Amgen; Antev; Asieris Pharmaceuticals; Astellas Pharma; AstraZeneca; Aura Biosciences; Bayer; Bioprotect; Bristol-Myers Squibb/Sanofi; CG Oncology; Clarity Pharmaceuticals; Dendreon; Exact Imaging; Ferring; Fize Medical; Glytherix; ImmunityBio; InVitae; Janssen Scientific Affairs; Lantheus Medical Imaging; Lilly; MDxHealth; Medivation/Astellas; Merck; Minomic; Myriad Genetics; Novartis; Nusano; Pfizer; Photocure; PlatformQ Health; Promaxo; Protara Therapeutics; Sanofi; Siemens; Speciality Networks; Sumitomo Pharma Oncology; Telix Pharmaceuticals; Tolmar; Tutelix; Urogen pharma Research Funding - Abbvie; Advantagene; Amgen; Aragon Pharmaceuticals; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; CG Oncology; Clovis Oncology; Dendreon; DisperSol; Endocyte; Exact Imaging; Exelixis; Ferring; FKD Therapies; FORMA Therapeutics; Foundation Medicine; Genentech; Guardant Health; InVitae; Istari Oncology; Janssen; Jiangsu Yahong Meditech; MDxHealth; Medivation; Merck; MT Group; Myovant Sciences; Myriad Genetics; Novartis; Nymox; OncoCellMDx; ORIC Pharmaceuticals; pacific edge; Palette Life Sciences; Pfizer; Plexxikon; POINT Biopharma; Propella Therapeutics; Propella Therapeutics; RhoVac; Sanofi; SeaGen; Sesen Bio; Steba Biotech; Theralase; Tolmar; Urogen pharma; Urotronic; US Biotest; Vaxiion; Veru; Zenflow   Xiao Wei Honoraria - OncLive Consulting or Advisory Role - AstraZeneca; Dendreon; Novartis; Novartis; Novartis; Novartis; Novartis Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Macrogenics (Inst); Novartis (Inst); Poseida (Inst) Travel, Accommodations, Expenses - Corvus Pharmaceuticals; Novartis   Jennifer Nguyen Employment - Novartis Stock and Other Ownership Interests - Novartis Travel, Accommodations, Expenses - Novartis   Jeetvan Patel Employment - Novartis Stock and Other Ownership Interests - Novartis   Diego Ospina Gonzalez Employment - Novartis Stock and Other Ownership Interests - Novartis Consulting or Advisory Role - FirstThought Travel, Accommodations, Expenses - Novartis   Barinder Kang Employment - Novartis Stock and Other Ownership Interests - Novartis   Clare Byrne Consulting or Advisory Role - Novartis (Inst) Research Funding - Novartis (Inst)   Jackson Tang Consulting or Advisory Role - Novartis (Inst) Research Funding - Novartis (Inst)   Daniel George Leadership - Capio BioSciences Stock and Other Ownership Interests - BMS; Pfizer Honoraria - Astellas Pharma; AstraZeneca; Axess Oncology; Bayer; Candel Therapeutics; Eisai; IDEOlogy Health; Janssen Oncology; Merck; Millennium Medical Publishing; Novartis; OncLive; Pfizer; Sumitomo; UroToday Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Candel Theraputics; Janssen; Merck Sharp & Dohme; Michael J. Hennessy Associates; Novartis; Pfizer; Physicans' Education Resource Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Convergent Therapeutics (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst) Expert Testimony - Exelixis Travel, Accommodations, Expenses - Bayer; Exelixis; Merck; Novartis; Pfizer